Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke

Experimental Neurology

Volumn 247, Issue , 2013, Pages 202-208

  Kuric, Enida ^a   Wieloch, Tadeusz ^a   Ruscher, Karsten ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Astrocytes; Dopamine receptor; Glial cell line derived neurotrophic factor; Glial fibrillary acidic protein; Levodopa; Stroke recovery

Indexed keywords

2,10,11 TRIHYDROXY N PROPYL NORAPORPHINE HYDROBROMIDE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENSERAZIDE PLUS LEVODOPA; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ETICLOPRIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LEVODOPA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GLIOSIS; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING;

ASTROCYTES; DOPAMINE RECEPTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LEVODOPA; STROKE RECOVERY;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; BRAIN; BRAIN INFARCTION; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LEVODOPA; MALE; NESTIN; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; STROKE;

EID: 84878876798     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.04.016     Document Type: Article

References (43)

1. Abe K., Hayashi T. Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion. Brain Res. 1997, 776:230-234.
2. Arvidsson A., Kokaia Z., Airaksinen M.S., Saarma M., Lindvall O. Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain. Neuroscience 2001, 106:27-41.
3. Blunt S.B., Jenner P., Marsden C.D. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with l-dopa and carbidopa. Exp. Brain Res. 1992, 88:326-340.
4. Calne D.B., Sandler M. l-Dopa and parkinsonism. Nature 1970, 226:21-24.
5. Chen L.W., Zhang J.P., Kwok-Yan S.D., Chan Y.S. Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice. J. Comp. Neurol. 2006, 497:898-909.
6. Chertoff M., Di P.N., Schoeneberg A., Depino A., Ferrari C., Wurst W., Pfizenmaier K., Eisel U., Pitossi F. Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor alpha in the nigrostriatal dopaminergic circuit of adult mice. Exp. Neurol. 2011, 227:237-251.
7. Cramer S.C., Chopp M. Recovery recapitulates ontogeny. Trends Neurosci. 2000, 23:265-271.
8. Cuello A.C. Experimental neurotrophic factor therapy leads to cortical synaptic remodeling and compensates for behavioral deficits. J. Psychiatry Neurosci. 1997, 22:46-55.
9. Deng L.X., Hu J., Liu N., Wang X., Smith G.M., Wen X., Xu X.M. GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Exp. Neurol. 2011, 229:238-250.
10. Fellin T. Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity. J. Neurochem. 2009, 108:533-544.
11. Garcia A.D., Doan N.B., Imura T., Bush T.G., Sofroniew M.V. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 2004, 7:1233-1241.
12. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996, 380:252-255.
13. Hosp J.A., Pekanovic A., Rioult-Pedotti M.S., Luft A.R. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. J. Neurosci. 2011, 31:2481-2487.
14. Howard S., Landry C., Fisher R., Bezouglaia O., Handley V., Campagnoni A. Postnatal localization and morphogenesis of cells expressing the dopaminergic D2 receptor gene in rat brain: expression in non-neuronal cells. J. Comp. Neurol. 1998, 391:87-98.
15. Hwang I.K., Yoo K.Y., Kim D.W., Lee B.H., Kang T.C., Choi S.Y., Han B.H., Kim J.S., Won M.H. Ischemia-related changes of glial-derived neurotrophic factor and phosphatidylinositol 3-kinase in the hippocampus: their possible correlation in astrocytes. Brain Res. 2006, 1072:215-223.
16. Kawashima S., Ueki Y., Kato T., Matsukawa N., Mima T., Hallett M., Ito K., Ojika K. Changes in striatal dopamine release associated with human motor-skill acquisition. PLoS One 2012, 7:e31728.
17. Kinor N., Geffen R., Golomb E., Zinman T., Yadid G. Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 2001, 33:143-150.
18. Kitagawa H., Hayashi T., Mitsumoto Y., Koga N., Itoyama Y., Abe K. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke 1998, 29:1417-1422.
19. Kuno R., Yoshida Y., Nitta A., Nabeshima T., Wang J., Sonobe Y., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 2006, 1116:12-18.
20. Laywell E.D., Rakic P., Kukekov V.G., Holland E.C., Steindler D.A. Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13883-13888.
21. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
22. Miyazaki H., Nagashima K., Okuma Y., Nomura Y. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res. 2001, 922:165-172.
23. Miyazaki I., Asanuma M., Diaz-Corrales F.J., Miyoshi K., Ogawa N. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res. 2004, 1029:120-123.
24. Nakajima K., Hida H., Shimano Y., Fujimoto I., Hashitani T., Kumazaki M., Sakurai T., Nishino H. GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res. 2001, 916:76-84.
25. Ohta K., Kuno S., Mizuta I., Fujinami A., Matsui H., Ohta M. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci. 2003, 73:617-626.
26. Ohta K., Kuno S., Inoue S., Ikeda E., Fujinami A., Ohta M. The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes. J. Neurol. Sci. 2010, 291:12-16.
27. Rocha S.M., Cristovao A.C., Campos F.L., Fonseca C.P., Baltazar G. Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiol. Dis. 2012, 47:407-415.
28. Rosser N., Heuschmann P., Wersching H., Breitenstein C., Knecht S., Floel A. Levodopa improves procedural motor learning in chronic stroke patients. Arch. Phys. Med. Rehabil. 2008, 89:1633-1641.
29. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 2002, 22:10291-10301.
30. Ruscher K., Johannesson E., Brugiere E., Erickson A., Rickhag M., Wieloch T. Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. J. Cereb. Blood Flow Metab. 2009, 29:1796-1805.
31. Ruscher K., Shamloo M., Rickhag M., Ladunga I., Soriano L., Gisselsson L., Toresson H., Ruslim-Litrus L., Oksenberg D., Urfer R., Johansson B.B., Nikolich K., Wieloch T. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 2011, 134:732-746.
32. Ruscher K., Kuric E., Wieloch T. Levodopa treatment improves functional recovery after experimental stroke. Stroke 2012, 43:507-513.
33. Saavedra A., Baltazar G., Duarte E.P. Driving GDNF expression: the green and the red traffic lights. Prog. Neurobiol. 2008, 86:186-215.
34. Sarabi A., Chang C.F., Wang Y., Hoffer B.J., Morales M. Time course study of GFRalpha-1 expression in an animal model of stroke. Exp. Neurol. 2001, 170:283-289.
35. Schaar D.G., Sieber B.A., Dreyfus C.F., Black I.B. Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 1993, 124:368-371.
36. Scheidtmann K., Fries W., Muller F., Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001, 358:787-790.
37. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
38. Treanor J.J., Goodman L., de S.F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature 1996, 382:80-83.
39. von Bohlen und H.O. Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus. Cell Tissue Res. 2011, 345:1-19.
40. Wang J., Lieberman D., Tabubo H., Finberg J.P., Oldfield E.H., Bankiewicz K.S. Effects of gliosis on dopamine metabolism in rat striatum. Brain Res. 1994, 663:199-205.
41. Wang Y., Lin S.Z., Chiou A.L., Williams L.R., Hoffer B.J. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 1997, 17:4341-4348.
42. Wei G., Wu G., Cao X. Dynamic expression of glial cell line-derived neurotrophic factor after cerebral ischemia. Neuroreport 2000, 11:1177-1183.
43. Zanassi P., Paolillo M., Montecucco A., Avvedimento E.V., Schinelli S. Pharmacological and molecular evidence for dopamine D(1) receptor expression by striatal astrocytes in culture. J. Neurosci. Res. 1999, 58:544-552.